Corporate Citizenship. Novartis gives preference to third parties who share Novartis’ societal and environmental values, as set forth in the Novartis Policy on Corporate Citizenship and Novartis Corporate Citizenship Guideline #5, both of which are attached as Schedule D and incorporated herein by reference. Accordingly, ImmunoGen represents and warrants that this Agreement will be performed in material compliance with all Applicable Laws and regulations, including, without limitation, laws and regulations relating to health, safety and the environment, fair labor practices and unlawful discrimination. Anything contained in this Agreement to the contrary notwithstanding, Novartis acknowledges and agrees that any breach by ImmunoGen of the representations, warranties and covenants set forth in this Section 11.20 shall not constitute a Material Breach, and that Novartis’ sole remedy in connection with any such breach shall be its right to terminate this Agreement pursuant to Section 8.2(a) hereof.
Corporate Citizenship. Novartis gives preference to Third Parties who share Novartis’ societal and environmental values, as set forth in the Novartis Policy on Corporate Citizenship and Novartis Corporate Citizenship Guideline #5, both of which are attached as Exhibit E and incorporated herein by reference. Accordingly, Company represents and warrants that this Agreement will be performed in material compliance with all applicable Laws and regulations, including, without limitation, Laws and regulations relating to health, safety and the environment, fair labor practices and unlawful discrimination.
Corporate Citizenship. Novartis gives preference to parties who share Novartis’ societal and environmental values as set forth in the “Novartis Third Party Code of Conduct” which is attached as Exhibit D.
Corporate Citizenship. 18 12. RECORDS; CONTROL REVIEW; AUDITS............................... 19 13. TERM.......................................................... 20 14.
Corporate Citizenship. By executing this Agreement, the Institution hereby re-confirms all representations and certifications made to Novartis through xxx.xxxxxxxxxxxxxxxxx.xxxxxxxx.xxx, if any, or otherwise in writing. Institution understands and agrees that (i) Novartis (1) has relied upon the accuracy and veracity of such representations and certifications; and (2) may use data from the same in submissions to the Federal government or other governmental authorities; and (ii) any misrepresentation in connection therewith shall constitute a material breach of this Agreement. Novartis endorses societal and environmental values as set forth in the Novartis Policy on Corporate Citizenship, Third Party Code of Conduct: (accessible at xxxx://xxx.xxxxxxxxxxxxxxxxxxxx.xxxxxxxx.xxx/downloads/business-conduct/NovartisTP_Code.pdf).
Corporate Citizenship. Novartis Diagnostics gives preference to third parties who share its societal and environmental values, as set forth in the Novartis Vaccines and Diagnostics, Inc.’s Corporate Citizenship Third Party Code (xxxx://xxx.xxxxxxxxxxxxxxxxxxxx.xxxxxxxx.xxx/downloads/business-conduct/Novartis_TP_Code.pdf) and incorporated by reference. Accordingly, Accler8 represents and warrants that this Agreement will be performed in material compliance with all applicable laws and regulations, including without limitation, laws and regulation relating to health, safety and the environment, fair labor practices and unlawful discrimination.
Corporate Citizenship. 1.5.1 Promote and maintain the standards set out in the Institute’s Code of Conduct; ensure that this is communicated to and fully understood by all Site Staff.
1.5.2 Ensure that the Site’s research fully meets current ethical standards, and adheres to guidelines from the University, and HDR UK Ltd and other bodies on ethics and good research practice.
1.5.3 Identify and seek to manage conflicts of interest which may arise in any aspect of the Site’s activities.
1.5.4 Ensure that any personal external interests and activities that may present a potential conflict of interest to HDR UK Ltd or any of the Funders are reported to and resolved by the Institute Director.
Corporate Citizenship. Provider agrees, when available, to provide ground ambulance stand-by at no charge for high school/college football games and other large scale events mutually agreed upon (i.e. Parades, Fourth of July Celebration) within the geographical boundaries of the Service Area. Upon request and acceptance, Provider agrees to provide such other stand-by service as is requested by the Service Area for similar events at a reduced charge. Provider also agrees to offer consolidated, annual First Responder training to the Service Area Firefighters in order to assist Provider with care in Emergency situations.
Corporate Citizenship. Common Ground® is a long-term community relations initiative designed to acquaint all of the Group’s stakeholders, in particular the communities living in the vicinity of our industrial sites, with ARKEMA’s activities and products.This initiative is based on listening, discussing, explaining, informing on the way our plants operate, the management of risks regarding health, safety and environment, ARKEMA’s innovation, and the everyday application of the products manufactured. Launched in France in 2002, the Common Ground® initiative has been gradually rolled out in every country in which ARKEMA operates through many types of actions: open days, plant tours, public information meetings, exhibitions, safety promotion days, events in schools, support to local organizations, etc. As part of this initiative, in the United States the Arkema Inc. Foundation strives to improve the quality of life in the communities based near the Group’s plants in North America, by providing backing to various social, cultural and educational organizations. The 2011 International Year of Chemistry (IYC) was a unique opportunity to promote, celebrate and publicise the key role played by chemistry in meeting the needs of society while providing solutions to sustainable development.The address by the Chairman and Chief Executive Officer of ARKEMA at the IYC official launch ceremony at the Unesco headquarters in January 2011, the Group’s active participation in events organised in France, including the IYC inaugural event “L’art en la matière”, and the road show “Vous avez dit chimie?” organised by the French Union des Industries Chimiques, the partnership established with Palais de la découverte in Paris, and the many Common Ground® initiatives demonstrated ARKEMA’s commitment to improving the image of chemistry and of the chemical industry. In 2011, the partnership between ARKEMA and Palais de la découverte was exemplified by two major operations aimed at celebrating the IYC with a series of events throughout the year. A high-tech chemistry laboratory adapted to public experiments was set up in the Palais for a program of presentations and talks entitled “Étonnante chimie” (Amazing chemistry). Inspired from ARKEMA innovations in four areas,“les liaisons secrètes des molécules” (The secret bonds of molecules),“le plastique qui se cultive” (Cultivating plastics), “une peinture verte quelle que soit sa couleur” (Green paint whatever its colour), and “du fluor high tech pour apprivoiser l’é...
Corporate Citizenship. Novartis gives preference to third parties who share Novartis' societal and environmental values, as set forth in the Novartis Policy on Corporate Citizenship, Guideline #5, Third Party Code . * The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange Commission. * The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange Commission. QUALITY AGREEMENT ON MANUFACTURING, (PACKAGING) AND TESTING NOVARTIS initials: ACCEPTOR initials: QAA Novartis Genvec - Core Document 31/6 Version 1.0 * The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange Commission. QUALITY AGREEMENT ON MANUFACTURING, (PACKAGING) AND TESTING PREAMBLE 35
